Molecular Staging of New Haven, Conn., has been awarded US Patent Number 6,368,801, “Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase.” The patent covers methods in which DNA strand-RNA strand complexes are ligated with T4 RNA ligase in order to facilitate amplification or detection of the nucleic acids, especially RNA sequences.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.